Markets
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Ipca Laboratories Ltd.
NSE: IPCALAB
|
BSE: 524494
|
ISIN: INE571A01038
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
1475.4000
-37.60
(
-2.49
%)
NSE
Mar 04, 2026
15:31 PM
26.30% Gain from 52W Low
Volume:
87,330
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Ipca Laboratories Ltd.
14 Feb 2025
1475.40
-2.49%
IPCA LABORATORIES
Accumulate:
Ipca Laboratories Ltd.
by
Prabhudas Lilladhar
Target: 1700
Prabhudas Lilladhar
ICICI Direct increased Buy price target of Ipca Laboratories Ltd. to 1800.0 on 17 Feb, 2026.
More from Ipca Laboratories Ltd.
Recommended
Market closes lower as Indian rupee hits record low amid Middle East tensions
Trendlyne Marketwatch |
04 Mar 2026, 03:54PM
Bad timing: New listings sink on debut amid market turmoil
|
02 Mar 2026
IPCA Labs’ domestic formulations business to drive growth
|
05 Jul 2021